Skip to content

Effect of traditional Chinese medicine Fuyang Yunshu on insulin resistance of obesity and metabolic syndrome

Effect of traditional Chinese medicine Fuyang Yunshu on insulin resistance of obesity and metabolic syndrome

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081884
Enrollment
Unknown
Registered
2024-03-14
Start date
2023-09-23
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Interventions

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of MS; 2. Aged from 18 to 80 years old; 3. Conforming to abdominal obesity: waist circumference >=90cm for men and =85cm for women; Or BMI>=25kg/m^2; 4. Patients with the TCM syndrome of spleen and kidney Yang deficiency, dampness and blood stasis; 5. Willing to obey the doctor's treatment plan and cooperate with follow-up, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe cardiac, hepatic and renal dysfunction (creatinine clearance =2.5 times upper limit of normal, total bilirubin >=1.5 times upper limit of normal; Chronic heart failure, cardiac function grade III and above). 2. Patients with malignant tumors; 3. Patients with acute cardio-cerebrovascular accident in the past 3 months; 4. Patients with acute infection; 5. Pregnant or lactating women; 6. The mentally ill person cannot understand the nature, scope and possible results of the study or cannot comply with the doctor's advice; 7. Those who were taking other similar interventions; 8. Secondary abnormal blood lipids, blood pressure and blood glucose; 9. Type 1 diabetes mellitus; 10. Patients with hyperthyroidism or hypothyroidism; Patients taking medications that affect body weight, such as glucocorticoids, contraceptives, and weight-loss drugs.

Design outcomes

Primary

MeasureTime frame
HOMA-IR;

Secondary

MeasureTime frame
Weight;Waistline;Body fat rate;Fasting blood-glucose;2-hour post-meal blood glucose;Glycosylated hemoglobin;Blood pressure;Total cholesterol;Triglyceride;High-density lipoprotein;Low density lipoprotein;Abdominal ultrasonography;Analysis of gut microbiota;TCM main symptom score;Clinical Global Impression Scale;EQ-5D Health Index scale;

Countries

China

Contacts

Public ContactQiyun Lu

Fangcun Hospital, Guangdong Provincial Hospital of Traditional Chinese Medicine

928710497@qq.com+86 134 3568 3615

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026